CSL Ltd
CSL: XASX (AUS)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| TX# | LOCK|>#N! | LOCK|NpGm^> |
CSL: Current Headwinds Appear More Structural and We Temper Our Long-Term Outlook
We have reflected on CSL's soft interim plasma result and temper our view. Immunoglobulin, or lg, sales, which made 57% of plasma sales, fell 6% year on year in constant currency. The former CEO hadn't executed as hoped, with plasma margins up just 10 basis points to 51%.
